Interestingly, AML1/ETO is necessary, but not sufficient for transformation or leukemia development, and a fraction of the AML1/ETO-expressing stem cells undergo additional oncogenic event(s) that ultimately leads to transformation into AML[44,45]. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.